Home

 

Production & Market  of

Ephedrine in China

 

 

Introduction & Summary: 
This multi-client report provides a preliminary study on the researched subject in China, from aspects of production, technology, import & export, consumption & end uses, etc.
All the producers in China, either active, idled or prospective, have been sourced and contacted. Their situation has been verified and compiled in the appendix.
 
The competitiveness of Chinese production is discussed in order to unravel the mystery of the ever-increasing capability of Chinese manufacturing.
 
An import & export analysis for the recent three years was conducted.
 
The consumption pattern of the researched subject has been analyzed in order to breakdown the end uses into different segments. The major end users for each end use segments have been identified.
 
Scientific methodology has been employed to conduct the quantitative forecast on this subject in the future 5-10 years.
 
Who needs this report: The aim of this report is to provide powerful assistance to strategy groups and management teams in making correct decisions in order to penetrate the ever-increasing China market and how to maximize or increase commercial opportunities. The report is formulated by professional market researchers, based on the first-hand and primary data which are analyzed by scientific methodology, confirmed with manufacturers, end users, or traders and legal authorities, and presented in a logical way.
Language: English
 
Last update: March 2006
 
Total pages: 154
Price:  US$5,000/ copy
 
Main Content:
  Executive Summary
I Production and Market
I-1 Ephedra Resources in China
I-1.1 Ephedrine Content in Ephedra & Properties of Chinese Ephedra
I-1.2 Ephedra Species & Distribution in China
I-1.3 Growth & Plantation of Ephedra in China
I-1.4 Collection of Ephedra in China (Natural & man-growth)
I-2 Brief History of Ephedrine Production in China
I-3 Current Situation of Ephedrine Production in China (L-ephedrine, pseudo ephedrine, methyl ephedrine and ephedra extract powder)
I-4 Brief Introduction to the Synthetic Ephedrine in China
I-5 Import & Export Analysis in the Recent Three Years
I-6 Pricing of Ephedrine in the Past
I-7 Consumption Pattern Ephedrine & Pseudo-ephedrine in China
I-8 Government Control
I-8.1 List of Relative Regulation
I-8.2 Management on Ephedrine Production
I-8.3 Management on Ephedrine Distribution
I-8.4 Management on Ephedrine Import & Export
I-9 Key Factors and Driven Forces for the Development of Ephedrine in China
II Technology
II-1 Extraction Process of Ephedrine
II-2 Chinese Approach to Synthetic Ephedrine & Current Progress
III Future Forecast on Ephedrine in the Next 5-10 Years
IV Appendix
IV-1 Profile of Major Producers
IV-2 List of Companies Licensed to Export Ephedrine & Its Derivatives
IV-3 List of Narcotic Drugs Distributors in China


 

Partial Content Preview:

Basically there are two kinds of ephedrine in China: Ephedrine from natural source (ephedra) and ephedrine by chemical synthesis. The majority are former ones.

 

Products species include L-ephedrine, pseudo-ephedrine, L-ephedrine sulfate, methyl ephedrine, etc. In recent years, the production of ephedra extract powder (6%, 8%, 10%) has been increasing.

 

Inherently the Chinese production of ephedrine & pseudo-ephedrine has been subject greatly to the ephedra supply, as well as the production quota issued by central government. The potential capacity of ephedrine in Xinjiang and Inner Mongolia is estimated to be xxxx MT/year and xxxx MT/year, respectively.

 

The production of L-ephedrine, pseudo-ephedrine in 2002 is xxxx MT and xxxx MT respectively. The export in 2002 is 7.4MT and 94.0MT, respectively.

 

The production of ephedra extract powder (6%, 8%, 10%) in 2002 is about xxxx MT, most of which are exported to USA.

 

In March 2003 the price of L-ephedrine, p-seudo-ephedrine and ephedra extract powder 6% is is USD40/kg FOB CMP, USD40 FOB CMP and USD6.8/kg FOB CMP, respectively.

 

Chinese government strictly controls the production, distribution and export of ephedrine.

(The remaining content of this report is omitted.)

 


 

 
Back to Top


 

Back to List of Reports

Order now